pfizer news
Latest from pfizer
Scientifically Speaking: Five years after Covid-19, mRNA vaccines still matter
Once hailed as a pandemic miracle, mRNA technology might revolutionise healthcare if we keep investing in it.

Updated on Mar 25, 2025 04:06 PM IST
ht_print |
Anirban Mahapatra
The great Indian debate on national champions
A growth path that is overly dependent on a few oligarchs may not answer the needs of a large and complex democracy

Published on Dec 02, 2024 08:15 PM IST
Pfizer drug helped cancer patients regain lost weight, study shows
Pfizer’s experimental cancer weight loss drug helped patients regain weight in a mid-stage study giving fresh promise for the dangerous muscle-wasting condition

Updated on Sep 15, 2024 03:54 PM IST
Bloomberg |
Five US states are suing Pfizer over COVID-19 vaccine safety, RFK Jr backs it
Independent presidential candidate Robert F. Kennedy Jr. criticizes Pfizer for deception; Kobach alleges concealment of vaccine risks and efficacy.

Published on Jun 26, 2024 09:53 AM IST
Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
SHIONOGI-CORONAVIRUS-PILL:Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial

Published on May 13, 2024 12:58 PM IST
Reuters |
After Boeing deaths, Pfizer ‘whistleblower’ puts out ‘I am not suicidal’ video
Former Pfizer employee Melissa McAtee had raised concerns about mRNA vaccines and potential harm, despite backlash.

Published on May 09, 2024 06:32 PM IST
Pfizer agrees to settle over 10,000 Zantac cancer lawsuits in US
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug.

Published on May 09, 2024 05:56 PM IST
Bloomberg |
Pfizer reports patient death in Duchenne gene therapy study
PFIZER-DUCHENNE/ (UPDATE 1):UPDATE 1-Pfizer reports patient death in Duchenne gene therapy study

Published on May 08, 2024 03:59 AM IST
Reuters |
Pfizer lifts profit view on cost cuts, smaller drop in demand for COVID products
PFIZER-RESULTS/ (UPDATE 2, PIX):UPDATE 2-Pfizer lifts profit view on cost cuts, smaller drop in demand for COVID products

Published on May 01, 2024 05:03 PM IST
Reuters |
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%. Here's why
Pfizer, which currently holds a 32% stake in Haleon, said last May it planned to cut its ownership in a "slow and methodical" manner within months.

Published on Mar 18, 2024 12:53 PM IST
Reuters |
A new year wish for good health
Major achievements in medical science in 2023 include mRNA technology for vaccines, CRISPR gene editing, 3D printing of human organs, and new drugs for weight loss and Alzheimer's. Utilization of continuous personal monitoring systems and artificial intelligence in healthcare also made significant progress. However, it is important to address poverty, nutrition, and access to healthcare to improve overall health.

Updated on Dec 31, 2023 11:13 PM IST
Pharmaceutical firms Pfizer, BioNTech sue Poland and Hungary over Covid debts
EU member countries ordered vaccines for their population through joint purchase scheme, and so companies are bringing their case before the courts in Belgium.

Published on Dec 19, 2023 07:52 PM IST
AFP |
Pfizer's updated Covid vaccine effective against 'Eris' variant in mice study
EG.5, nicknamed by some as "Eris", is similar to the XBB.1.5 subvariant and a sub-lineage of the still-dominant Omicron variant.

Published on Aug 18, 2023 12:50 AM IST
Reuters |
Video: Tornado rips through Pfizer manufacturing plant amid drug shortage in US
The disaster struck as the US was facing a nine-year-high of drug shortages — 309 medicines are in short supply.

Updated on Jul 22, 2023 06:55 AM IST
US drug regulator approves world's first RSV vaccine
Respiratory Syncytial Virus vaccine: RSV normally causes mild, cold-like symptoms, but can be serious for people with weak immune systems.

Published on May 04, 2023 01:26 AM IST
AFP |
High air pollution hits Covid vaccine response: Study
The research team measured three kinds of antibodies (IgM, IgG and IgA) to five viral antigens (three of them on the spike protein contained in the vaccine).

Updated on Apr 07, 2023 06:06 AM IST
HT Correspondent, New Delhi
Jairam Ramesh dismisses Union minster's 'pushing for foreign vaccine' claims
Congress' Jairam Ramesh dismissed claims made in a Twitter post shared by the Union minister- Rajeev Chandrasekhar over the grand old party pushing for Pfizer vaccine at a time when the pharmaceutical company was “bullying” the Centre for its acceptance.

Updated on Jan 23, 2023 06:57 AM IST
, New Delhi
Snehashish Roy‘Will Twitter have guts?’: Jairam amps up attack on minister over Pfizer vaccine
Union minister Rajeev Chandrasekhar shared a video on Twitter on Friday about Pfizer CEO Albert Bourla's encounter with a journalist at Davos 2023, and blamed Congress leaders Jairam Ramesh, Rahul Gandhi and P Chidambaram for pushing the case of foreign Covid-19 vaccines in India.

Updated on Jan 21, 2023 01:24 PM IST
Sharangee Dutta, New Delhi
Davos 2023: Pfizer CEO evades questions on Covid vaccine efficacy. Watch video
The Pfizer chief time and again ducked the questions, only to say "Thank you very much" and "Have a nice day".

Published on Jan 20, 2023 02:13 PM IST
ANI | | Posted by Ritu Maria Johny
Pfizer's Paxlovid antiviral can lower post-Covid symptoms by 26%: Study
The research, based on an analysis of electronic health records in databases maintained by the Department of Veterans Affairs, is the first study to look at Paxlovid’s longer-term effects, said Eric Topol, founder of the Scripps Research Translational Institute in La Jolla, California.

Published on Nov 07, 2022 01:20 PM IST
Bloomberg |
Pfizer probed in Italy for allegedly hiding $1.2 billion profit
Pfizer’s Italian unit began operating almost 70 years ago and employs about 2,000 workers, according to its website.

Published on Oct 27, 2022 02:33 AM IST
Bloomberg |
Pfizer seeks approval of updated COVID vaccine booster against new variants
Vaccines targeting the coronavirus strain that spread in early 2020 and their effectiveness against infection has dropped markedly as new mutants came along, particularly the super-contagious omicron family.

Published on Aug 23, 2022 03:35 PM IST
AP | | Posted by Yagya Sharma
Pfizer files application for booster against latest variants
In a statement, the companies said they had “rapidly scaled production” for the new booster and would be able to ship doses of the new vaccine “immediately” upon emergency authorization.

Published on Aug 22, 2022 11:08 PM IST
Bloomberg |
CDC advisers urge Pfizer booster for children ages 5 to 11
If the Centers for Disease Control and Prevention agrees, as expected, it would open a third Covid-19 shot to healthy elementary-age kids — just like what is already recommended for everybody 12 and older.

Published on May 20, 2022 03:47 AM IST
AP |
US authorises Covid booster shots for children aged 5 to 11
Children will become eligible for the booster at least five months after completing their initial vaccine doses. The dosage is 10 micrograms for both the initial shots and the booster, compared to 30 for those 12 and older.

Published on May 17, 2022 11:25 PM IST
AFP |
Pfizer’s Covid drug fails test for preventing infections
The drug, Paxlovid, failed to meet its primary goal of significantly reducing the risk of Covid-19 infection in adults exposed to the virus through a household contact, Pfizer said in a statement Friday.

Published on Apr 30, 2022 05:44 AM IST
Bloomberg |
Pfizer’s third Covid shot boosts antibodies in kids 5 to 11
The companies plan to file for emergency-use authorization in the US in the coming days based on the results, according to a statement Thursday. They will also submit the data to other regulators around the world.

Published on Apr 14, 2022 07:59 PM IST
Bloomberg |
Made in India Covid vaccines better than Pfizer, Moderna: SII's Adar Poonawalla
Speaking to ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna."

Published on Apr 13, 2022 04:22 PM IST
ANI |
Pfizer made 6 million courses of its Covid pill, shipped to over 26 countries
Pfizer spokesperson Sharon Castillo said in an email that the company has shipped the pills to over 26 countries so far.

Published on Apr 05, 2022 06:57 AM IST
Reuters |
FDA okays 2nd booster of Pfizer, Moderna
For most people, the second booster will be a fourth shot, while it will be the third for those who got initial single-shot immunisations from Johnson & Johnson.

Updated on Mar 30, 2022 07:32 AM IST
Agencies | , London
- 1
- 2
- ...